PhaseBio Pharmaceuticals (PHAS) null Earnings

14NovConfirmed
Oct 18
May 19
Aug 19
Nov 19
-10.45
-7.07
-3.68
-0.3

Details

Expected EPS
-0.37
Actual EPS
-0.4
Surprise EPS
-0.03
Surprise Percent
+8.11%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -0.4 per share for .

0 Comments

Share your thoughts